Clinical Trial

To Evaluate Long- Term Safety and Efficacy of Luspatercept

Study acronym: LUSPAREAL001
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
An observational study to evaluate long-term safety and efficacy of luspatercept in subjects with transfusion dependent who received the first dose of luspatercept after its introduction in the clinical practice
Trial Details
NCT Number NCT06875219
Lead Sponsor Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia
Conditions Thalassemia Major
Enrollment 350 participants
Start Date 2023-04-30
Primary Completion 2025-02-24 (estimated)
Study Completion 2026-02-24 (estimated)
Updated on ClinicalTrials.gov 2025-03-13